On Thursday 30 January 2020, Telstra Health and Research Australia co-hosted an event highlighting the vital role of digital technology in Australia’s changing health system. Research Australia members and Telstra Health partners from across the entire health and medical research pipeline convened to network and share their thoughts on this important subject over a drink to see in the new year.
Telstra Health’s Managing Director and Research Australia Board Director, Professor Mary Foley AM and Nadia Levin, Research Australia’s CEO and Managing Director, both spoke at the event sharing their views on the developing role of information technology in all aspects of health and health and medical research.
Professor Foley provided her insights on Telstra Health’s role supporting governments, health system managers, and healthcare providers to deliver high quality, equitable, and accessible care in an increasingly complex and specialised health system.
Nadia Levin highlighted the growing need for Australia’s health sector to utilise the many revolutionary benefits current and future digital information technologies can provide. Nadia gave examples from Research Australia’s members making ground-breaking progress in digital technology and later took a moment away from space medicine to focus on the patient, who is at the core of all health and medical research. Focusing on current health outcomes, Nadia acknowledged how something as simple as a digital sensor in an incontinence pad can positively impact a patient in aged care.
The evening included a Q&A session with an interactive audience wanting further discussion on the importance of addressing Australia’s health data privacy concerns. The Frontiers Health and Medical Research funding initiative was also a hot topic of discussion with attendees highlighting the need for greater acknowledgement of the innovative and research-based nature of digital information technology.
Research Australia welcomes the news that one of our members, the University of Queensland, has been asked to develop a vaccine for the recent Wuhan Coronavirus outbreak. Through the use of new technologies, the University plans to develop the vaccine within an unprecedented timeframe of 6 months. If successfully discovered, the vaccine may be used as a primary strategy to contain the coronavirus outbreak.
Click here to see the University of Queensland’s news article.
Scientists from the University of Melbourne and The Royal Melbourne Hospital’s Doherty Institute are the first to share successfully grown Wuhan Coronavirus in a laboratory setting. As a member of Research Australia, we commend the University of Melbourne and the Doherty Institute for their important breakthrough that will play a key role in speeding up diagnosis and aid in the development of a vaccine.
Click here to view the Doherty Institute’s media release.